OncoHost is a series c plus startup based in Israel. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
OncoHost is developing a platform that combines proteomic analysis with AI to predict patient response to immunotherapy and identify new potential drug targets, aiming to advance personalized cancer therapy.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky